Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Rectal leiomyosarcoma. 4 new cases].

J P Cailliez-Tomasi1, O Bouché, C Avisse

  • 1Service de Chirurgie Générale et Digestive, CHU Robert Debré, Reims.

Gastroenterologie Clinique Et Biologique
|July 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-EGFR-based maintenance versus stop and go in patients with left-sided, non-MSI-H, RAS/BRAF-wt metastatic colorectal cancer: individual patient data pooled analysis.

ESMO open·2026
Same author

Dihydropyrimidine dehydrogenase phenotype-guided dose individualization of fluoropyrimidine in gastrointestinal cancers: PRODIGE100-UCGI48-FUDOSE phase II study.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026
Same author

Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study.

medRxiv : the preprint server for health sciences·2026
Same author

Molecular analysis in pancreatic adenocarcinoma: a real-world study from high-volume French centres (CAPANCOBIO study).

ESMO gastrointestinal oncology·2026
Same author

Effect of 5 years of CT-scan and CEA follow-up on survival endpoints in patients with colorectal cancer: the PRODIGE-13 FFCD phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Regorafenib combined with irinotecan as second-line treatment in metastatic gastro-oesophageal adenocarcinomas: results of PRODIGE 58-UCGI35-REGIRI Unicancer randomised phase II study.

ESMO open·2025
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
See all related articles

Endoscopic ultrasonography aids in diagnosing rectal leiomyosarcoma, guiding treatment decisions. Local excision is effective for localized rectal tumors, while advanced cases may require abdominoperineal resection and adjuvant therapies.

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Oncology

Background:

  • Rectal leiomyosarcoma is a rare malignancy.
  • Accurate diagnosis and staging are crucial for effective treatment planning.

Observation:

  • Four cases of rectal leiomyosarcoma were evaluated.
  • Endoscopic ultrasonography (EUS) was used for initial suspicion.
  • Surgical approaches included local excision (Kraske's approach) and abdominoperineal resection.

Findings:

  • EUS provided precise lesion estimation, aiding treatment selection.
  • Leiomyosarcoma confined to the rectal wall was successfully treated with local excision.
  • Wide surgical margins are essential for complete tumor removal.
  • Histological stage and metastatic status dictate further therapeutic strategies.

Related Experiment Videos

  • Two patients received radiation therapy.
  • Chemotherapy (doxorubicin) showed benefit for higher-grade sarcomas regarding recurrence and survival.

    • Implications:

    • EUS is a valuable tool for rectal leiomyosarcoma diagnosis and treatment planning.
    • Local excision can be a viable option for early-stage rectal leiomyosarcoma.
    • Multimodal treatment approaches, including surgery, radiation, and chemotherapy, are important for managing advanced rectal leiomyosarcoma.